Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coiffier

Showing results (181-190 of 289) with videos related to

Pageof 29
Sort By:
Annales De Medecine Interne|January 1, 1993
[Clinical study of 12 cases of malignant non-Hodgkin's lymphoma of the orbital region]G Salles, M Vignal, J Ninet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsC Dumontet, J Jaubert, C Sebban, et al.
Blood|March 9, 2000
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patientsF Berger, P Felman, C Thieblemont, et al.
Bone Marrow Transplantation|April 18, 2002
Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myelomaO Hequet, C Dumontet, A El Jaafari-Corbin, et al.
Bone Marrow Transplantation|March 23, 2004
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphomaB Lemieux, S Tartas, C Traulle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Frequency and significance of anemia in non-Hodgkin's lymphoma patientsI Moullet, G Salles, N Ketterer, et al.
American Journal of Clinical Pathology|April 1, 1994
Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survivalM Ffrench, J P Magaud, P Ffrench, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
The British Journal of Dermatology|June 13, 2008
Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphomaE Bathelier, L Thomas, B Balme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimenA Bosly, B Coiffier, C Gisselbrecht, et al.
Pageof 29

Showing results (181-190 of 289) with videos related to

Sort By:
Pageof 29
Annales De Medecine Interne|January 1, 1993
[Clinical study of 12 cases of malignant non-Hodgkin's lymphoma of the orbital region]G Salles, M Vignal, J Ninet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsC Dumontet, J Jaubert, C Sebban, et al.
Blood|March 9, 2000
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patientsF Berger, P Felman, C Thieblemont, et al.
Bone Marrow Transplantation|April 18, 2002
Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myelomaO Hequet, C Dumontet, A El Jaafari-Corbin, et al.
Bone Marrow Transplantation|March 23, 2004
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphomaB Lemieux, S Tartas, C Traulle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Frequency and significance of anemia in non-Hodgkin's lymphoma patientsI Moullet, G Salles, N Ketterer, et al.
American Journal of Clinical Pathology|April 1, 1994
Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survivalM Ffrench, J P Magaud, P Ffrench, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
The British Journal of Dermatology|June 13, 2008
Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphomaE Bathelier, L Thomas, B Balme, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimenA Bosly, B Coiffier, C Gisselbrecht, et al.
Pageof 29